Ticker Short Interest

URGN Short Interest Intelligence

UroGen Pharma Ltd positioning pressure, squeeze risk, bearish conviction, crowding, days to cover, and price-positioning divergence.

Latest settlement 30 Jun 2026 Neutral

Neutral

Covering Rally

URGN is classified as Neutral. Latest reported short interest is 6.2M shares; short interest changed -5.2%, price moved +16.2% since the previous report, short interest is in the 14th percentile, and days to cover is in the 43th percentile. Trend context is constructive.

Setup Score46/100Neutral
Reported Short Interest6.2M-5.2% vs prior report
Days To Cover9.4242.86 percentile
Price Reaction+16.2%since previous short report
Squeeze Pressure46crowding, trend, and pressure
Bearish Conviction11shorts adding into weakness

Reported Short Interest

2026-03-31 to 2026-06-30

Days To Cover

liquidity pressure

Short Interest Change

report-to-report

Price Context

2026-03-20 to 2026-06-26

Squeeze Radar

46

Elevated short interest becomes most interesting when price strength forces shorts to defend or cover.

Bearish Conviction

11

Rising short interest alongside weak trend can mean the bearish trade is being reinforced, not trapped.

Crowding

27

Latest short interest is 6.2M shares and days to cover is 9.42.

Divergence

0

Short interest fell while price rose. The bearish trade appears to be unwinding into strength.

Report History

URGN Short Interest Ledger

Most recent first
SettlementShort interestPreviousChangeDays coverAverage volume
30 Jun 2026 6218229 6557146 -5.2% 9.42 660094
15 Jun 2026 6557146 6921016 -5.3% 9.87 664053
29 May 2026 6921016 6764905 2.3% 11.09 623859
15 May 2026 6764905 7236438 -6.5% 5.82 1162466
30 Apr 2026 7236438 7826923 -7.5% 8.88 814957
15 Apr 2026 7826923 8348466 -6.3% 11.19 699218
31 Mar 2026 8348466 8629222 -3.3% 11.83 705960

Short interest is delayed, reported on a periodic schedule, and may be revised. The dashboard is research context only and does not prove real-time short activity.